153 related articles for article (PubMed ID: 25501934)
1. Heavy/light chain assay for monitoring IgA multiple myeloma: digging out the IgA from the β region.
Calderon B
Clin Chem; 2015 Feb; 61(2):317-8. PubMed ID: 25501934
[No Abstract] [Full Text] [Related]
2. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
3. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
[TBL] [Abstract][Full Text] [Related]
4. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
5. Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.
Suehara Y; Takamatsu H; Fukumoto K; Fujisawa M; Narita K; Usui Y; Takeuchi M; Endean K; Matsue K
Cancer Sci; 2017 Feb; 108(2):187-192. PubMed ID: 27889936
[TBL] [Abstract][Full Text] [Related]
6. Detecting only light chains, now what?
Jacobs JF; Joosten I; Klasen IS
Clin Chem; 2010 Aug; 56(8):1368. PubMed ID: 20668174
[No Abstract] [Full Text] [Related]
7. Evaluation of the heavy/light-chain assay for the diagnosis and monitoring of multiple myeloma.
Chae H; Cha K; Kim M; Kim Y; Min CK
Int J Lab Hematol; 2013 Oct; 35(5):e10-2. PubMed ID: 23311353
[No Abstract] [Full Text] [Related]
8. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
9. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
Ansari NA; Owais M; Usha
Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
[TBL] [Abstract][Full Text] [Related]
11. Within-subject biological variation of pairs of heavy/light immunoglobulin IgM chains (HLC IgM κ and λ) is low and requires monitoring: A comparison with HLC IgA, HLC IgG, and free light immunoglobulin chains (FLC) in healthy subjects.
Jabor A; Kubíček Z; Komrsková J; Sečník P; Vacková T; Vymětalík J; Franeková J
Clin Chim Acta; 2018 Nov; 486():311-312. PubMed ID: 30125534
[No Abstract] [Full Text] [Related]
12. Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.
Kamiya Y; Chou T; Murakami H; Handa H; Ozaki S; Shimazaki C; Fuchida SI; Okada J; Itoh J; Sugiyama S; Shimizu K
Hematol Oncol; 2019 Aug; 37(3):316-318. PubMed ID: 30938836
[No Abstract] [Full Text] [Related]
13. [Light chain escape followed by leukemic transformation with IgA multiple myeloma: a case report].
Cheng L; Zhou Q; Wang Y; Liu S
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):352. PubMed ID: 27094005
[No Abstract] [Full Text] [Related]
14. Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.
D'Auria F; La Rocca F; Simeon V; Statuto T; Pietrantuono G; D'Arena G; Villani O; Mansueto G; Traficante A; Musto P
Br J Haematol; 2018 May; 181(4):550-552. PubMed ID: 28439880
[No Abstract] [Full Text] [Related]
15. The utility of the serum heavy/light chain assay as a complementary tool in the monitoring of patients with plasma cell myeloma: a report of three cases.
Kim H; Lee JK; Hong YJ; Hong SI; Shin DY; Kang HJ; Chang YH
Ann Clin Lab Sci; 2015; 45(2):193-8. PubMed ID: 25887874
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients.
Batinić J; Perić Z; Šegulja D; Last J; Prijić S; Dubravčić K; Volarić L; Sertić D; Radman I; Bašić-Kinda S; Matišić D; Batinić D; Labar B; Nemet D
Croat Med J; 2015 Jun; 56(3):263-71. PubMed ID: 26088851
[TBL] [Abstract][Full Text] [Related]
17. A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.
Katzmann JA; Rajkumar SV
Leukemia; 2013 Jan; 27(1):1-2. PubMed ID: 23299499
[No Abstract] [Full Text] [Related]
18. Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma.
Claveau JS; Savary Bélanger S; Ahmad I; Delisle JS; De Guire V; Roy J; LeBlanc R
Blood Cancer J; 2022 Jan; 12(1):3. PubMed ID: 34987163
[No Abstract] [Full Text] [Related]
19. Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay.
Turner KA; Eckelkamp LL; Kalass SJ; Martinez MA; Brewer HR; Hoyne JB; Snyder MR; Murray DL; Willrich MAV
Clin Chem; 2019 Oct; 65(10):1327-1329. PubMed ID: 31387883
[No Abstract] [Full Text] [Related]
20. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
